Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1669.20
-31.35 (-1.84%)
< Home < Back

Sun Pharma likely to invest Rs 450 crore for capex in FY12

Date: 31-05-2011

Sun Pharmaceutical Industries, an international specialty pharma company is planning to spend Rs 450 crore for capacity expansion and up gradation of existing plants, including its Taro facilities, in the current fiscal. On September 20, 2010 Israel based Taro pharmaceutical industries became Sun Pharma's subsidiary.

The company is also planning to expand its operations in both US and emerging markets. The company expects a growth of 28-30% in the current fiscal.

The company registered 34.42% increase in its consolidated net profit after minority interest for year ended March 31, 2011 at Rs 1816.06 crore as compared to Rs 1351.08 crore for the year ended March 31, 2010. Total income for the year has increased by 42.96% at 5859.98 crore as compared to Rs 4098.90 crore for the previous year.